Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Investigational- Compassionate Use of Convalescent Plasma From COVID-19 Donors in Oncological and Non-Oncological Patients With Severity Criteria: FALP 001-2020 Trial (FALP-COVID)

NCT04384588 is registered in ClinicalTrials.gov with Fundacion Arturo Lopez Perez as lead sponsor.

NCT NCT04384588
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04384588 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Investigational- Compassionate Use of Convalescent Plasma From COVID-19 Donors in Oncological and Non-Oncological Patients With Severity Criteria: FALP 001-2020 Trial (FALP-COVID)
Lead sponsor
Fundacion Arturo Lopez Perez
Phase
Phase 2/3
Overall status
Unknown status
Start date
April 7, 2020
Completion date
April 6, 2021
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer patients, covid-19 infection, general population